To Evaluate the Safety and Efficacy of TQ Formula in Covid-19 Participants

NCT04914377 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
55
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novatek Pharmaceuticals